BCL2 and lymphoma: By this time, Tim McDonnell in Stan Korsmeyer’s laboratory had beaten them to make Eμ-Bcl-2 transgenic mice [25], but shortly before Vaux headed off to Stanford, the first three Eμ-Myc/Eμ-Bcl-2 double transgenic mice had developed lymphoma at only a few weeks of age, confirming the oncogenic synergy between these two oncogenes.